Andreas Scherr

933 total citations
26 papers, 581 citations indexed

About

Andreas Scherr is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Andreas Scherr has authored 26 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 10 papers in Physiology and 2 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Andreas Scherr's work include Chronic Obstructive Pulmonary Disease (COPD) Research (22 papers), Respiratory Support and Mechanisms (11 papers) and Asthma and respiratory diseases (7 papers). Andreas Scherr is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (22 papers), Respiratory Support and Mechanisms (11 papers) and Asthma and respiratory diseases (7 papers). Andreas Scherr collaborates with scholars based in Switzerland, Netherlands and Spain. Andreas Scherr's co-authors include Michael Tamm, Daiana Stolz, David Miedinger, Sabrina Maier, Jörg D. Leuppi, Beat P. Müller‐Stich, Sébastien Viatte, Matthias Briel, Tilman Drescher and Christoph Henzen and has published in prestigious journals such as JAMA, CHEST Journal and European Respiratory Journal.

In The Last Decade

Andreas Scherr

26 papers receiving 564 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Scherr Switzerland 14 437 201 79 41 39 26 581
R. Stoeckli Switzerland 7 242 0.6× 331 1.6× 71 0.9× 36 0.9× 36 0.9× 10 680
R. A. Stone United Kingdom 7 467 1.1× 205 1.0× 40 0.5× 17 0.4× 16 0.4× 8 538
Renata Ferrari Brazil 14 365 0.8× 179 0.9× 41 0.5× 34 0.8× 56 1.4× 39 562
Catherina L. Chang New Zealand 13 382 0.9× 156 0.8× 89 1.1× 17 0.4× 119 3.1× 40 552
Li Ping Chung Australia 11 272 0.6× 261 1.3× 28 0.4× 18 0.4× 18 0.5× 18 419
Hannah Whittaker United Kingdom 11 266 0.6× 102 0.5× 53 0.7× 31 0.8× 43 1.1× 46 375
Eleni Karetsi Greece 12 279 0.6× 148 0.7× 28 0.4× 36 0.9× 42 1.1× 33 426
Ivar Ellingsen Norway 9 513 1.2× 247 1.2× 29 0.4× 25 0.6× 47 1.2× 14 600
Aikaterini Haniotou Greece 7 217 0.5× 100 0.5× 29 0.4× 8 0.2× 45 1.2× 14 304
Andrea Akemi Morita Brazil 12 282 0.6× 260 1.3× 40 0.5× 40 1.0× 62 1.6× 28 510

Countries citing papers authored by Andreas Scherr

Since Specialization
Citations

This map shows the geographic impact of Andreas Scherr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Scherr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Scherr more than expected).

Fields of papers citing papers by Andreas Scherr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Scherr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Scherr. The network helps show where Andreas Scherr may publish in the future.

Co-authorship network of co-authors of Andreas Scherr

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Scherr. A scholar is included among the top collaborators of Andreas Scherr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Scherr. Andreas Scherr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Scherr, Andreas, Desirée Schumann, Meropi Karakioulaki, et al.. (2020). Endothelial dysfunction is not a predictor of outcome in chronic obstructive pulmonary disease. Respiratory Research. 21(1). 90–90. 5 indexed citations
2.
Lorenz, Lisa, et al.. (2019). Pembrolizumab in a Patient With a Metastatic CASTLE Tumor of the Parotid. Frontiers in Oncology. 9. 14 indexed citations
3.
Scherr, Andreas, et al.. (2018). Airway reactivity to mannitol is similarly increased in chronic cigarette and water pipe smokers. International Journal of COPD. Volume 13. 157–163. 5 indexed citations
4.
Mandal, Jyotshna, Michael Roth, Eleni Papakonstantinou, et al.. (2017). Treatment with long acting muscarinic antagonists stimulates serum levels of irisin in patients with COPD. Pulmonary Pharmacology & Therapeutics. 48. 111–116. 4 indexed citations
5.
Scherr, Andreas, et al.. (2015). Predictors of marked weight gain in a population of health care and industrial workers following smoking cessation. BMC Public Health. 15(1). 520–520. 17 indexed citations
6.
Schüetz, Philipp, Jörg D. Leuppi, Roland Bingisser, et al.. (2015). Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the Reduction in the Use of Corticosteroids in Exacerbated COPD (REDUCE) trial. European Journal of Endocrinology. 173(1). 19–27. 21 indexed citations
7.
Mandal, Jyotshna, Michael Roth, Luigi Costa, et al.. (2015). Vasoactive Intestinal Peptide for Diagnosing Exacerbation in Chronic Obstructive Pulmonary Disease. Respiration. 90(5). 357–368. 14 indexed citations
8.
Stolz, Daiana, Renaud Louis, Wim Boersma, et al.. (2014). COPD-specific co-morbidity test (COTE) for predicting mortality in COPD – Results of an European, multicenter study. European Respiratory Journal. 44(Suppl 58). P566–P566. 3 indexed citations
9.
Stolz, Daiana, Wim Boersma, Francesco Blasi, et al.. (2014). Exertional Hypoxemia in Stable COPD Is Common and Predicted by Circulating Proadrenomedullin. CHEST Journal. 146(2). 328–338. 22 indexed citations
10.
Riet, Gerben ter, Pierre‐Olivier Bridevaux, Prashant N. Chhajed, et al.. (2014). The ADO Index as a Predictor of Two-Year Mortality in General Practice-Based Chronic Obstructive Pulmonary Disease Cohorts. Respiration. 88(3). 208–214. 23 indexed citations
11.
Leuppi, Jörg D., Philipp Schüetz, Roland Bingisser, et al.. (2014). Short-term vs Conventional Glucocorticoid Therapy in Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Survey of Anesthesiology. 58(2). 77–78. 1 indexed citations
12.
Stolz, Daiana, et al.. (2014). Mortality risk prediction in COPD by a prognostic biomarker panel. European Respiratory Journal. 44(6). 1557–1570. 33 indexed citations
13.
Stolz, Daiana, et al.. (2013). Predictors of Success for Smoking Cessation at the Workplace: A Longitudinal Study. Respiration. 87(1). 18–25. 24 indexed citations
14.
Leuppi, Jörg D., Philipp Schüetz, Roland Bingisser, et al.. (2013). Short-term vs Conventional Glucocorticoid Therapy in Acute Exacerbations of Chronic Obstructive Pulmonary Disease. JAMA. 309(21). 2223–2223. 256 indexed citations
15.
Scherr, Andreas, Rolf Graf, Mirjam Christ‐Crain, et al.. (2013). Pancreatic Stone Protein Predicts Positive Sputum Bacteriology in Exacerbations of COPD. CHEST Journal. 143(2). 379–387. 21 indexed citations
16.
Jochmann, Anja, et al.. (2012). Impact of adherence to GOLD guidelines on symptom prevalence, lung function decline and exacerbation rate in a Swiss COPD cohort. Swiss Medical Weekly. 142(1314). w13567–w13567. 35 indexed citations
17.
Scherr, Andreas, Anja Jochmann, David Miedinger, et al.. (2012). Response to Add-on Inhaled Corticosteroids in COPD Based on Airway Hyperresponsiveness to Mannitol. CHEST Journal. 142(4). 919–926. 17 indexed citations
18.
Leuppi, Jörg D., Philipp Schütz, Roland Bingisser, et al.. (2012). Short term glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: “REDUCE*”, a non-inferiority multicenter trial. (*Reduction in the Use of Corticosteroids in Exacerbated COPD; ISRCTN19646069). 40. 4293. 1 indexed citations
19.
Stolz, Daiana, Κonstantinos Κostikas, Francesco Blasi, et al.. (2012). Combined assessment according to the new GOLD guidelines and its relation to outcome in COPD. 40. 1648. 1 indexed citations
20.
Scherr, Andreas, Francesco Blasi, & Daiana Stolz. (2011). An update on exacerbation in COPD. 50(2). 129–146. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Stoeckli Breakdown of academic impact, for papers by R. A. Stone Breakdown of academic impact, for papers by Renata Ferrari Breakdown of academic impact, for papers by Catherina L. Chang Breakdown of academic impact, for papers by Li Ping Chung Breakdown of academic impact, for papers by Hannah Whittaker Breakdown of academic impact, for papers by Eleni Karetsi Breakdown of academic impact, for papers by Ivar Ellingsen Breakdown of academic impact, for papers by Aikaterini Haniotou Breakdown of academic impact, for papers by Andrea Akemi Morita
Rankless by CCL
2026